Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Director/PDMR Shareholding

11 Jan 2024 09:45

RNS Number : 3956Z
Redcentric PLC
11 January 2024
 

Redcentric plc

Director/PDMR Shareholdings

Redcentric plc (AIM:RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, received notification from Kestrel Partners LLP ("Kestrel") that on 08 January 2024 and 09 January 2024 it purchased, on behalf of its discretionary client accounts, an aggregate of 16,144 ordinary shares of 0.1 pence each ("Ordinary Shares") in the Company at an average price of £1.2635 per Ordinary Share.

Mr Oliver Scott is a partner of, and holds a beneficial interest in, Kestrel. Mr Scott is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Redcentric.

Following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 16,402,618 Ordinary Shares in the Company, and other clients of Kestrel, in which Mr Scott has no beneficial interest, hold 15,601,345 Ordinary Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 32,003,963 Ordinary Shares in the Company, which represents approximately 20.47 per cent of the total voting rights in the Company.

Kestrel's interest in the Shares in the Company is held through the following nominees:

Holding type

Nominee

No. of Ordinary Shares

% of total voting rights

Indirect

Bank of New York Nominees Ltd

16,402,618

10.49%

Indirect

JIM Nominees Limited

464,310

0.30%

Indirect

Bank of New York Nominees Ltd

12,238,465

7.83%

Indirect

Northern Trust Company AVFC

2,898,570

1.85%

 

For further information contact:

 

Redcentric plc

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

 +44 (0) 800 983 2522

 

 

Cavendish Capital Markets Limited (NOMAD and Sole Broker)

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

 

+44 (0) 20 7220 0500

 

 

 

 

 

 

ANNEX

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kestrel Partners LLP

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Oliver Scott (non-executive director Redcentric plc)

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Redcentric plc

b)

 

LEI

 

213800FGYMMNE9OKFD14

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Identification code

0.1 pence Ordinary Shares

 

ISIN: GB00B7TW1V39

b)

 

Nature of the transaction

 Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

Transfer

 

Purchase

 

08 January 2024

Price(s)

Volume(s)

£1.26456

 12,363

 

09 January 2024

Price(s)

Volume(s)

£1.26

 3,781

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

 

Purchase Total of 16,144 Ordinary Shares at a price of £1.2635

e)

 

Date of the transaction

 

08 January 2024, 09 January 2024

f)

 

Place of the transaction

London AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBMLTMTTBMPI
Date   Source Headline
1st Jun 20267:01 amRNSAppointment of Chief Financial Officer
1st Jun 20267:00 amRNSTrading Update
13th May 20261:25 pmRNSCapital Reduction Result of General Meeting
12th May 20267:00 amRNSExercise of Options
1st May 20267:00 amRNSCompletion of Sale of Redcentric Data Centres Ltd
24th Apr 20267:00 amRNSProposed Capital Reduction & Notice of GM
14th Apr 20267:00 amRNSExercise of Options
8th Apr 202612:55 pmRNSDirector/PDMR Shareholdings
19th Mar 20263:26 pmRNSExercise of Options
13th Mar 20267:00 amRNSExercise of Options
13th Mar 20267:00 amRNSExercise of Options
23rd Feb 20261:00 pmRNSHolding(s) in Company
20th Feb 20267:00 amRNSExercise of Options
9th Jan 202610:09 amRNSExercise of Options
31st Dec 202512:15 pmRNSDirector/PDMR Share Dealing
31st Dec 202512:15 pmRNSDirector/PDMR Share Dealing
31st Dec 20257:00 amRNSExercise of Options
31st Dec 20257:00 amRNSExercise of Options
29th Dec 20257:01 amRNSDirector/PDMR Share Dealing
29th Dec 20257:01 amRNSDirector/PDMR Share Dealing
29th Dec 20257:00 amRNSReplacement: Director/PDMR Share Dealing
29th Dec 20257:00 amRNSReplacement: Director/PDMR Share Dealing
24th Dec 20259:55 amRNSDirector/PDMR Share Dealing
24th Dec 20259:55 amRNSDirector/PDMR Share Dealing
22nd Dec 202511:46 amRNSGrant of Options
22nd Dec 202511:46 amRNSGrant of Options
12th Dec 20253:49 pmRNSDirector/PDMR Shareholdings
11th Dec 20257:00 amRNSExercise of Options
10th Dec 20257:00 amRNSHalf Year Results
4th Dec 20257:00 amRNS-RPresentation via Investor Meet Company
14th Nov 20257:00 amRNSExercise of Options
6th Nov 20258:00 amRNSSAYE Share Option Scheme
5th Nov 20257:00 amRNSH1 Trading Update and Notice of Results
27th Oct 20254:36 pmRNSHolding(s) in Company
24th Oct 20257:00 amRNSExercise of Options
23rd Oct 20257:00 amRNSDisposal of Redcentric Data Centres Limited
20th Oct 20254:48 pmRNSResult of AGM
17th Oct 202512:40 pmRNSExercise of Options
13th Oct 20259:40 amRNSExercise of Options
3rd Oct 20257:00 amRNSExercise of Options
25th Sep 20257:00 amRNSPublication of Annual Report and Notice of AGM
24th Sep 20257:00 amRNSFinal Results
2nd Sep 20257:00 amRNSNotice of Final Results
22nd Aug 20251:13 pmRNSResponse to recent press speculation
19th Aug 20257:00 amRNSAppointment of Chief Financial Officer
1st Aug 20257:00 amRNSExercise of Options
7th Jul 20257:00 amRNSExercise of Options
23rd Jun 20257:00 amRNSExercise of Options
17th Jun 20257:00 amRNSHolding(s) in Company
28th May 20253:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.